Scaling Smarter: Navigating Life Sciences Regulation & Antitrust Risk from Seed to Exit

As digital health and life sciences companies scale, regulatory and antitrust complexity can quickly outpace internal resources. This session will provide practical, stage-specific guidance for mitigating risk while supporting growth. Topics will include:

• Key compliance issues across federal and state regulations, commercialization, and privacy
• Common antitrust pitfalls in communications, hiring, and strategic partnerships
• How to prepare for increased scrutiny from Series A through IPO or acquisition